Literature DB >> 16697988

Synthesis of multivalent lactose derivatives by 1,3-dipolar cycloadditions: selective galectin-1 inhibition.

Johan Tejler1, Erik Tullberg, Torbjörn Frejd, Hakon Leffler, Ulf J Nilsson.   

Abstract

Acetylene derivatives of phenylalanine, phenethylamine and the multifunctional unnatural amino acids, phenyl-bis-alanine and phenyl-tris-alanine, were synthesized and functionalized with 2-azidoethyl beta-D-galactopyranosyl-(1-->4)-beta-D-glucopyranoside via regioselective copper(I)-mediated 1,3-dipolar cycloaddition to give a panel of mono-, di- and trivalent lactoside derivatives. Evaluation of the compounds as inhibitors against the tumour- and inflammation-related galectin-1, -3, -4N, -4C, -4, -7, -8N and -9N revealed a divalent compound with a Kd value as low as 3.2 microM for galectin-1, which corresponded to a relative potency of 30 per lactose unit as compared to the natural disaccharide ligand lactose. This divalent compound had at least one order of magnitude higher affinity for galectin-1 than for any of the other galectins investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697988     DOI: 10.1016/j.carres.2006.04.028

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  14 in total

1.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.

Authors:  Ruud P M Dings; Nigam Kumar; Michelle C Miller; Melissa Loren; Huzaifa Rangwala; Thomas R Hoye; Kevin H Mayo
Journal:  J Pharmacol Exp Ther       Date:  2012-12-11       Impact factor: 4.030

Review 3.  Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.

Authors:  Vanessa Leiria Campo; Marcelo Fiori Marchiori; Lílian Cataldi Rodrigues; Marcelo Dias-Baruffi
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

4.  Crystallization and preliminary crystallographic analysis of recombinant human galectin-1.

Authors:  Stacy A Scott; Ken Scott; Helen Blanchard
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-10-24

5.  Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities.

Authors:  Juan M Pérez Sáez; Pablo F Hockl; Alejando J Cagnoni; Santiago P Méndez Huergo; Pablo A García; Sabrina G Gatto; Juan P Cerliani; Diego O Croci; Gabriel A Rabinovich
Journal:  Angiogenesis       Date:  2020-10-01       Impact factor: 9.596

6.  Significant rate accelerated synthesis of glycosyl azides and glycosyl 1,2,3-triazole conjugates.

Authors:  Rishi Kumar; Prakas R Maulik; Anup Kumar Misra
Journal:  Glycoconj J       Date:  2007-12-18       Impact factor: 2.916

7.  Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding.

Authors:  Ruud P M Dings; Michelle C Miller; Irina Nesmelova; Lucile Astorgues-Xerri; Nigam Kumar; Maria Serova; Xuimei Chen; Eric Raymond; Thomas R Hoye; Kevin H Mayo
Journal:  J Med Chem       Date:  2012-05-30       Impact factor: 7.446

8.  A Study of Solvent Effects in the Solvolysis of Propargyl Chloroformate.

Authors:  Malcolm J D'Souza; Anthony M Darrington; Dennis N Kevill
Journal:  ISRN Org Chem       Date:  2011

9.  Glycodendrimers: tools to explore multivalent galectin-1 interactions.

Authors:  Jonathan M Cousin; Mary J Cloninger
Journal:  Beilstein J Org Chem       Date:  2015-05-12       Impact factor: 2.883

10.  Synthesis, antimicrobial and cytotoxicity evaluation of new cholesterol congeners.

Authors:  Mohamed Ramadan El Sayed Aly; Hosam Ali Saad; Shams Hashim Abdel-Hafez
Journal:  Beilstein J Org Chem       Date:  2015-10-16       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.